GAM Systematic’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$982K Buy
13,479
+1,999
+17% +$144K 0.14% 286
2017
Q2
$851K Buy
11,480
+10,787
+1,557% +$801K 0.12% 313
2017
Q1
$51K Sell
693
-8,201
-92% -$574K 0.01% 561
2016
Q4
$582K Sell
8,894
-6,150
-41% -$422K 0.14% 296
2016
Q3
$1.11M Sell
15,044
-1,422
-9% -$105K 0.23% 150
2016
Q2
$1.21M Buy
16,466
+8,239
+100% +$587K 0.29% 98
2016
Q1
$581K Buy
+8,227
New +$547K 0.15% 283

Other funds holding CL

GAM Systematic's CL Position: Q3 2017 in Review

GAM Systematic increased its Colgate-Palmolive (CL) stake by 17% in Q3 2017, buying an estimated $144K and bringing the position to 13,479 shares worth $982K. The position accounts for 0.14% of the portfolio, ranked #286.

GAM Systematic first reported a position in CL in Q1 2016 and has held it in 7 quarters since. The position peaked at $1.21M in Q2 2016. 1,357 funds tracked by Wall St. Rank hold CL as of Q3 2017.

  • GAM Systematic held 13,479 shares of Colgate-Palmolive worth $982K as of Q3 2017.
  • GAM Systematic bought 1,999 Colgate-Palmolive shares in Q3 2017, an estimated $144K.
  • Colgate-Palmolive made up 0.14% of GAM Systematic's portfolio in Q3 2017, its #286 holding.
  • GAM Systematic first reported a position in Colgate-Palmolive in Q1 2016 and has held it in 7 quarters since.
  • GAM Systematic's Colgate-Palmolive position peaked at $1.21M in Q2 2016.
  • 1,357 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.